The IRB Approves Requested Changes
The IRB approved the requested changes, conditional to accepting changes in the consent documents. Dr. Mithoefer accepted all changes the IRB recommended. Now the investigators can continue to plan and …
MP1: Proof Of Principle Study
A Letter from the National Institute of Mental Health About MDMA
A letter from the National Institute of Mental Health (NIMH) arrived at MAPS today, saying that our grant application, “Treatment Manual Development for MDMA-Assisted Therapy,” has been received …
Michael Mithoefer Submits Proposed Changes
Michael Mithoefer submitted proposed changes to the MDMA/PTSD, including provisions for videotaping all psychotherapy sessions, a step needed for developing a treatment manual for MDMA-assisted psychotherapy …
Grant Application to NIMH Submitted
Michael Mithoefer MD submitted a grant application to NIMH for developing a treatment manual of MDMA-assisted therapy for PTSD.
The Scientist: Renewed Faith in Ecstasy
An article in The Scientist magazine by Alison McCook discusses struggles with DEA over MAPS’ psychedelic and medical marijuana research protocols. Originally appearing here. [MAPS Notes in brackets …
Today Michael and Ann Mithoefer performed the fi
Today Michael and Ann Mithoefer performed the first experimental (MDMA or placebo) session for the sixth participant enrolled in the study of MDMA-assisted psychotherapy in people with PTSD. If all goes …
At the request of our Institutional Review Board
At the request of our Institutional Review Board (IRB), MAPS has established a Data Safety Monitoring Board (DSMB) that works for MAPS reviewing the data from Dr. Mithoefer’s MDMA/PTSD study on an …
The McLean IRB Approved Shortened Informed Consent Form
The McLean IRB approved the shortened informed consent form for the MAPS-sponsored pilot study designed to explore the use of MDMA-assisted psychotherapy in subjects with anxiety associated with advanced …
The Lahey Clinic Institutional Review Board (IR
The Lahey Clinic Institutional Review Board (IRB) met this evening to review the MAPS-sponsored pilot study designed to explore the use of MDMA-assisted psychotherapy in subjects with anxiety associated …
The second experimental session for the 4th subject
The second experimental session for the 4th subject in the MDMA/PTSD study took place today. The session went very well. The next Data Safety Monitoring Board (DSMB) meeting will take place after the 5th …
MAPS’ Data Safety Monitoring Board (DSMB)
MAPS’ Data Safety Monitoring Board (DSMB) for the MDMA/PTSD study met today to review the data on the first five subjects who participated in at least one experimental session. The DSMB was comfortable …
Third subject treated in MAPS Flagship MDMA Study
The third subject in the MDMA/PTSD study participated in the second (and final) experimental session. The experimental sessions have all been scheduled on Fridays, which is working out to be a convenient …